GAVI documents

The 2010 Work Plan Report highlights the 2010 progress under each output of the 2007-2010 work plan.

This paper provides a response to the IFFIm Evaluation by the IFFIm Board of Directors. 

The World Bank has reviewed an evaluation report of the International Finance Facility for Immunisation (IFFIm) prepared by HLSP and dated June 2011. The World Bank provides services to IFFIm under the Treasury Management Agreement and this report substantially reviews those activities in the context of IFFIm’s overall performance as a financing vehicle.

This evaluation was commissioned by the GAVI Secretariat, on behalf of the IFFIm Board, to assess the extent to which the IFFIm has been an effective financing mechanism to raise money for immunisation and health systems in GAVI eligible countries.

The International Financing Facility for Immunisation (IFFIm) concept is proven. IFFIm has allowed donor countries to make binding long-term commitments and convert these future cash flows into immediately available funds through the financial markets at a cost very close to that achieved by the World Bank. 

Donors feel that the report presents valuable information about the goal effectiveness, costs effectiveness, and impacts in terms of lives saved by IFFIm. The evaluation shows, while highlighting constraints (size), lost opportunities (frontloading too early) and potential challenges (sustainability), that IFFIm has so far achieved impacts beyond those specifically targeted for immunisation.

GAVI Secretariat response to IFFIm evaluation which assessed both IFFIm’s efficacy as a financing mechanism, as well as the extent to which IFFIm has contributed to enhancing GAVI’s impact on immunisation and health.

The IFFIm evaluation assesses the extent to which IFFIm is an effective and efficient instrument to attract long-term, predictable donor funds and to frontload money to finance GAVI Alliance support for immunisation and health systems.

1 . A. 21 February 2011 Evaluation of the International Finance Facility for Immunisation (IFFIm) ANNEXES April 2011 HLSP, Sea Containers House, 20 Upper Ground, London SE1 9LZ, United Kingdom T +44 (0)20 7803 4545 F +44 (0)20 7803 4502, W www.hlsp.org Evaluation of the International Finance Facility for Immunisation (

This evaluation seeks to answer two high-level questions: to what extent has the GAVI Alliance met its four Strategic Goals (SGs); and to what extent has the GAVI Alliance added value at the global and country levels, over and above what would have been accomplished without the Alliance?

Childhood pneumonia is a major public health issue in Kenya; it is the second leading cause of death among children under five. Thanks to the AMC, two vaccines (PCV10 and PCV13) against pneumococcal disease have been approved so far for introduction in GAVI-eligible countries.